
|Articles|March 1, 2012
Preventing recurrent urinary tract infections: Is a vaccine still feasible?
David Klumpp, PhD, and David T. Uehling, MD, explain the challenges inherent in developing a vaccine for UTI and discuss the status of current research.
Advertisement
Q. Please discuss how you became interested in a urinary tract infection vaccine.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5











